Drug safety check for vulnerable patients
NCT ID NCT07345689
Summary
This study aims to understand how a single dose of the drug anaprazole sodium is processed by the body and how safe it is in specific groups of people. It will enroll about 60 adults, including healthy volunteers, elderly people, and people with moderate liver or kidney problems. Researchers will compare how the drug behaves in these different groups to ensure it can be used safely.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ELDERLY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Bethune Hospital of Jilin University
Changchun, Jilin, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.